24小时热门版块排行榜    

查看: 448  |  回复: 1
本帖产生 1 个 ,点击这里进行查看

xiandongzeng

木虫 (正式写手)

已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

baiyuefei

版主 (文学泰斗)

风雪

优秀版主优秀版主优秀版主文献杰出贡献优秀版主优秀版主优秀版主文献杰出贡献优秀版主优秀版主优秀版主优秀版主文献杰出贡献优秀版主优秀版主优秀版主优秀版主优秀版主优秀版主

【答案】应助回帖

★ ★ ★ ★ ★
感谢参与,应助指数 +1
xiandongzeng: 金币+5, ★★★★★最佳答案, 3Ks 2018-09-18 09:12:29
心静_依然: LS-EPI+1, 感谢应助 2018-09-19 08:37:31
DcR3 combined with hematological traits serves as a valuable biomarker for the diagnosis of cancer metastasis
作者:Li, JX (Li, Junxin)[ 1,2 ] ; Xie, N (Xie, Ni)[ 3 ] ; Yuan, JH (Yuan, Jianhui)[ 4 ] ; Liu, LY (Liu, Lvyan)[ 1 ] ; Zhou, QM (Zhou, Qiming)[ 5 ] ; Ren, XH (Ren, Xiaohu)[ 4 ] ; Chen, Q (Chen, Qian)[ 1,2 ] ; Zhang, GZ (Zhang, Guizhong)[ 1 ] ; Ruan, QG (Ruan, Qingguo)[ 1 ] ; Chen, YHH (Chen, Youhai H.)[ 6 ] ...更多内容

ONCOTARGET

卷: 8  期: 64  页: 107612-107620
DOI: 10.18632/oncotarget.22544

出版年EC 8 2017

文献类型:Article

查看期刊影响力

摘要
Decoy receptor 3 (DcR3) is abnormally up-regulated in many cancer cells. It may help cancer cells to escape from immune surveillance and establish metastatic lesions. However, whether DcR3 can be used as a biomarker for the diagnosis of cancer metastasis is unclear. In this study, sera from healthy controls and patients with different cancers were collected, and tested for their DcR3 levels by ELISA. Significantly elevated DcR3 levels were observed in the sera of patients with gastric cancer (2.04 +/- 1.01, P = 0.0061), lymphoma (1.62 +/- 0.75, P = 0.041), and breast cancer (1.53 +/- 0.51, P = 0.023). DcR3 was found to be a suitable biomarker for identifying gastric cancer patients. Importantly, DcR3 was positively associated with platelet distribution width (PDW) (P = 2.45 x 10(-6), R = 0.63) in metastatic cancers but negatively associated with hemoglobin (HGB) (P = 0.002, R = -0.59) and hematocrit (HCT) (P = 0.001, R = -0.62) in non-metastatic cancers. Combined with PDW, HGB and HCT, serum DcR3 could be used to predict the occurrence of cancer metastasis. These findings indicate that DcR3 could be used as a biomarker for the diagnosis of gastric cancer, and for cancer metastasis in combination with hematological traits.

关键词
作者关键词cR3; PDW; HGB; HCT; metastasis

KeyWords PlusECOY RECEPTOR-3; E-CADHERIN; GASTRIC-CANCER; CELL-ADHESION; COLON-CANCER; EXPRESSION; PROGRESSION; CARCINOMA; APOPTOSIS; CATENIN

作者信息
通讯作者地址: Wan, XC (通讯作者)

显示更多        Univ City Shenzhen, Shenzhen Lab Fully Human Antibody Engn, Inst Biomed & Biotechnol, Shenzhen Inst Adv Technol,Chinese Acad Sci, Shenzhen 518055, Peoples R China.
地址:

显示更多        [ 1 ] Univ City Shenzhen, Shenzhen Lab Fully Human Antibody Engn, Inst Biomed & Biotechnol, Shenzhen Inst Adv Technol,Chinese Acad Sci, Shenzhen 518055, Peoples R China
显示更多        [ 2 ] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
显示更多        [ 3 ] Shenzhen Second Peoples Hosp, Inst Translat Med, Shenzhen 518035, Peoples R China
              [ 4 ] Shenzhen Ctr Dis Control & Prevent, Inst Toxicol, Shenzhen 518055, Peoples R China
              [ 5 ] Nanshan Hosp Shenzhen, Dept Oncol, Shenzhen 518055, Peoples R China
显示更多        [ 6 ] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
电子邮件地址:xc.wan@siat.ac.cn

基金资助致谢
基金资助机构        授权号
Shenzhen Peacock Team Project        
1110140040347265
Fourth Batch of Talents Project in Guangdong Province        
2014-1
Nature Science Foundation of China        
81373112
Shenzhen Special Funds of Industry in the Future        
2015-971
Shenzhen Municipal Development and Reform Commission (NDRC) Engineering Laboratory Project        
2014-1782
Project of Guangdong Natural Science Foundation        
2016A030310033
Project of Shenzhen Basic Research Plan        
JCYJ20150402102135491
JCYJ201603 28161613864
Shenzhen Technology Innovation Progect        
JSGG20160229202150023
JSGG20140701164558078
JCYJ20150330102720122
Project of Shenzhen International Cooperation Foundation        
GJHZ201603 01163138685
GJHZ20130412153906740
Natural Science Foundation of Guangdong        
2016A030313029
Natural Science Foundation of China        
81501356
Project of Guangdong Scientific Plan Foundation        
2013A022100037
2013B021800097
2014A020212038
查看基金资助信息   
出版商
IMPACT JOURNALS LLC, 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA

类别 / 分类
研究方向:Oncology; Cell Biology

Web of Science 类别:Oncology; Cell Biology

文献信息
语言:English

入藏号: WOS:000419564600024

PubMed ID: 29296192

ISSN: 1949-2553

其他信息
IDS 号: FS1UR

Web of Science 核心合集中的 "引用的参考文献": 41

Web of Science 核心合集中的 "被引频次": 0
2楼2018-09-18 08:48:11
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 xiandongzeng 的主题更新
信息提示
请填处理意见